Depression and risk of developing dementia

Depression is highly common throughout the life course and dementia is common in late life. Depression has been linked with dementia, and growing evidence implies that the timing of depression may be important in defining the nature of this association. In particular, earlier-life depression (or depressive symptoms) has consistently been associated with a more than twofold increase in dementia risk. By contrast, studies of late-life depression and dementia risk have been conflicting; most support an association, yet the nature of this association (for example, if depression is a prodrome or consequence of, or risk factor for dementia) remains unclear. The likely biological mechanisms linking depression to dementia include vascular disease, alterations in glucocorticoid steroid levels and hippocampal atrophy, increased deposition of amyloid-β plaques, inflammatory changes, and deficits of nerve growth factors. Treatment strategies for depression could interfere with these pathways and alter the risk of dementia. Given the projected increase in dementia incidence in the coming decades, understanding whether treatment for depression alone, or combined with other regimens, improves cognition is of critical importance. In this Review, we summarize and analyze current evidence linking late-life and earlier-life depression and dementia, and discuss the primary underlying mechanisms and implications for treatment.

[1]  K. Hashimoto,et al.  Critical role of brain-derived neurotrophic factor in mood disorders , 2004, Brain Research Reviews.

[2]  R. Maccioni,et al.  Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease. , 2008, Archives of medical research.

[3]  J. Groves,et al.  Is it time to reassess the BDNF hypothesis of depression? , 2007, Molecular Psychiatry.

[4]  Z Walker,et al.  Microglial activation and amyloid deposition in mild cognitive impairment , 2009, Neurology.

[5]  C. Halldin,et al.  A PET study of , 2000, The international journal of neuropsychopharmacology.

[6]  Filippo Caraci,et al.  Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. , 2010, European journal of pharmacology.

[7]  M. Marinelli,et al.  Age matters , 2009, The European journal of neuroscience.

[8]  D. Price,et al.  The neuropathology of aminergic nuclei in Alzheimer's disease , 1988, Progress in clinical and biological research.

[9]  A. Zonderman,et al.  Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment , 2010, Neurology.

[10]  J. Becker,et al.  Pathways linking late-life depression to persistent cognitive impairment and dementia , 2008, Dialogues in clinical neuroscience.

[11]  Janet B W Williams Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[12]  Olga V. Demler,et al.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[13]  J. Lindsay,et al.  Vascular dementia : incidence and risk factors in the Canadian study of health and aging. , 2000, Stroke.

[14]  J. Payne,et al.  The Geriatric Mental State Examination in the 21st century , 2002, International journal of geriatric psychiatry.

[15]  A. Zonderman,et al.  Depressive symptoms, sex, and risk for Alzheimer's disease , 2005, Annals of neurology.

[16]  M. Maj,et al.  The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression , 2009, Metabolic Brain Disease.

[17]  K. Yaffe,et al.  Midlife versus late-life depression and risk of dementia: Differential effects for vascular dementia and Alzheimer's disease , 2010, Alzheimer's & Dementia.

[18]  A. Hofman,et al.  History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease , 2008, Neurology.

[19]  S. Rubin,et al.  Inflammatory markers and cognition in well-functioning African-American and white elders , 2003, Neurology.

[20]  R. Rao Cerebrovascular disease and late life depression: an age old association revisited , 2000, International journal of geriatric psychiatry.

[21]  A. Green,et al.  Depression and the Risk of Alzheimer Disease , 2005, Epidemiology.

[22]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[23]  O. Wolkowitz,et al.  Depression gets old fast: do stress and depression accelerate cell aging? , 2010, Depression and anxiety.

[24]  R. Kuljiš,et al.  The Role of Neuroimmunomodulation in Alzheimer's Disease , 2009, Annals of the New York Academy of Sciences.

[25]  L. Flicker Vascular factors in geriatric psychiatry: time to take a serious look , 2008, Current opinion in psychiatry.

[26]  J. Ferro,et al.  White matter changes and late-life depressive symptoms , 2007, British Journal of Psychiatry.

[27]  M. Takeda,et al.  [Vascular depression]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[28]  D. Steffens,et al.  Change in hippocampal volume on magnetic resonance imaging and cognitive decline among older depressed and nondepressed subjects in the neurocognitive outcomes of depression in the elderly study. , 2011, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[29]  Abraham Weizman,et al.  Increased risk for dementia in elderly psychiatric inpatients with late-onset major depression. , 2000, The Journal of nervous and mental disease.

[30]  Thomas Hagen,et al.  Hippocampal volume reduction and HPA-system activity in major depression. , 2007, Journal of psychiatric research.

[31]  M. Murer,et al.  Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease , 2001, Progress in Neurobiology.

[32]  L. Schneider,et al.  Sertraline for the treatment of depression in Alzheimer disease. , 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[33]  S. Kanba,et al.  Anti-inflammatory effects of antidepressants: possibilities for preventives against Alzheimer's disease. , 2009, Central nervous system agents in medicinal chemistry.

[34]  C. Pittenger,et al.  Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms , 2008, Neuropsychopharmacology.

[35]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[36]  F. Lezoualc’h 5-HT4 receptor and Alzheimer's disease: The amyloid connection , 2007, Experimental Neurology.

[37]  B. McEwen,et al.  The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. , 1986, Endocrine reviews.

[38]  D. Swaab,et al.  The stress system in the human brain in depression and neurodegeneration , 2005, Ageing Research Reviews.

[39]  M. Webster,et al.  Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium , 2004, Molecular Psychiatry.

[40]  R Brookmeyer,et al.  Prevalence of dementia after age 90 , 2008, Neurology.

[41]  1 The GloBAl eCoNomiC impACT oF demeNTiA Alzheimer ’ s diseAse internAtionAl World Alzheimer report 2010 the GlobAl economic impAct of dementiA , 2022 .

[42]  A. Caspi,et al.  Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene , 2003, Science.

[43]  C. Cotman The Role of Neurotrophins in Brain Aging: A Perspective in Honor of Regino Perez-Polo , 2005, Neurochemical Research.

[44]  A. Sierksma,et al.  Major depression, cognitive dysfunction and Alzheimer's disease: is there a link? , 2010, European journal of pharmacology.

[45]  J. Saczynski,et al.  The Honolulu-Asia Aging Study , 2007 .

[46]  Louis Valiquette,et al.  10 years later... , 2013, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[47]  P. Modrego,et al.  Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. , 2004, Archives of neurology.

[48]  B. Leonard Inflammation, Depression and Dementia: Are they Connected? , 2007, Neurochemical Research.

[49]  K. Yaffe,et al.  Dysthymia and depression increase risk of dementia and mortality among older veterans. , 2012, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[50]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[51]  Anil Gholkar,et al.  A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. , 2004, The American journal of psychiatry.

[52]  F. Schmidt Meta-Analysis , 2008 .

[53]  B. Pollock,et al.  Persistence of neuropsychologic deficits in the remitted state of late-life depression. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[54]  K. Krishnan,et al.  Does antidepressant therapy improve cognition in elderly depressed patients? , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.

[55]  J. Dartigues,et al.  Exploring Sex Differences in the Relationship Between Depressive Symptoms and Dementia Incidence: Prospective Results From the PAQUID Study , 2003, Journal of the American Geriatrics Society.

[56]  S. Brophy,et al.  Interventions for latent autoimmune diabetes (LADA) in adults. , 2011, The Cochrane database of systematic reviews.

[57]  Glenda M MacQueen,et al.  Course of illness, hippocampal function, and hippocampal volume in major depression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Casey Crump,et al.  Cerebrovascular Disease and Evolution of Depressive Symptoms in the Cardiovascular Health Study , 2002, Stroke.

[59]  D. Jolley,et al.  Cost benefits of a medically supervised day treatment program for patients with Alzheimer's disease and other forms of dementia , 1989 .

[60]  P. Buckley Apolipoprotein E ε4 Allele Genotype and the Effect of Depressive Symptoms on the Risk of Dementia in Men: The Honolulu-Asia Aging Study , 2009 .

[61]  Philip B. Ward,et al.  Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression , 2005, British Journal of Psychiatry.

[62]  J. Copeland,et al.  A standardized interview for the elderly (GMS): Reliability studies comparing the Dutch language version with the original , 1991 .

[63]  Dora Kanellopoulos,et al.  Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction. , 2010, The American journal of psychiatry.

[64]  W. Taylor,et al.  The brain-derived neurotrophic factor Val66Met polymorphism, hippocampal volume, and cognitive function in geriatric depression. , 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[65]  B. Pollock,et al.  Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. , 2003, Journal of psychiatric research.

[66]  R. Green,et al.  Depression as a risk factor for Alzheimer disease: the MIRAGE Study. , 2003, Archives of neurology.

[67]  Allison Druin,et al.  Age matters , 2002 .

[68]  P. S. St John,et al.  Do depressive symptoms predict Alzheimer's disease and dementia? , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[69]  A. Hofman,et al.  Cerebral white matter lesions and depressive symptoms in elderly adults. , 2000, Archives of general psychiatry.

[70]  C. Cotman PL6.1 Keynote lecture: Exercise builds brain health: key roles of growth factor cascades and inflammation , 2008 .

[71]  L. Sifonios,et al.  Chronic treatment with high doses of corticosterone decreases cytoskeletal proteins in the rat hippocampus , 2006, The European journal of neuroscience.

[72]  Lukas Scheef,et al.  No association of the Val66Met polymorphism of the brain-derived neurotrophic factor with hippocampal volume in major depression , 2009, Psychiatric genetics.

[73]  J. Becker,et al.  Depressed mood is not a risk factor for incident dementia in a community-based cohort. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[74]  A. Caspi,et al.  Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene , 2003, Science.

[75]  J. Kim,et al.  Stress effects in the hippocampus: Synaptic plasticity and memory , 2006, Stress.

[76]  Gérard Waeber,et al.  Geriatric depression and vascular diseases: what are the links? , 2004, Journal of affective disorders.

[77]  H. Sackeim,et al.  Randomized double‐blind placebo‐controlled donepezil augmentation in antidepressant‐treated elderly patients with depression and cognitive impairment: a pilot study , 2008, International journal of geriatric psychiatry.

[78]  E. Cankurtaran,et al.  Risk factors and type of dementia: vascular or Alzheimer? , 2008, Archives of gerontology and geriatrics.

[79]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[80]  A. Versace,et al.  P.1.b.002 Anterior cingulate volumes in schizophrenia: a systematic research review and a meta-analysis of MRI studies , 2006, European Neuropsychopharmacology.

[81]  Anthony F Jorm History of Depression as a Risk Factor for Dementia: An Updated Review , 2001, The Australian and New Zealand journal of psychiatry.

[82]  G. Alexopoulos,et al.  'Vascular depression' hypothesis. , 1997, Archives of general psychiatry.

[83]  Deanna M Barch,et al.  Regional white matter hyperintensity burden in automated segmentation distinguishes late-life depressed subjects from comparison subjects matched for vascular risk factors. , 2008, The American journal of psychiatry.

[84]  G. Alexopoulos The Vascular Depression Hypothesis: 10 Years Later , 2006, Biological Psychiatry.

[85]  H. Braak,et al.  Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease , 2009, Acta Neuropathologica.

[86]  Lester C. Loschky,et al.  What Is the Relationship , 1994 .

[87]  H. Manji,et al.  Life Stress, Genes, and Depression: Multiple Pathways Lead to Increased Risk and New Opportunities for Intervention , 2004, Science's STKE.

[88]  Ruoling Chen,et al.  Severity of depression and risk for subsequent dementia: cohort studies in China and the UK , 2008, British Journal of Psychiatry.

[89]  M. Folstein,et al.  Amyloid-associated depression: a prodromal depression of Alzheimer disease? , 2008, Archives of general psychiatry.

[90]  T. Dening,et al.  Antidepressants for treating depression in dementia. , 2002, The Cochrane database of systematic reviews.

[91]  L. Radloff The CES-D Scale , 1977 .

[92]  Carl W. Cotman,et al.  Exercise builds brain health: key roles of growth factor cascades and inflammation , 2007, Trends in Neurosciences.

[93]  Yun Hu,et al.  Activation of 5-HT4 receptors inhibits secretion of β-amyloid peptides and increases neuronal survival , 2007, Experimental Neurology.

[94]  J. Copeland,et al.  Dementia and depression in elderly persons: Agecat compared with dsm III and pervasive illness , 1990 .

[95]  David Loewenstein,et al.  Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. , 2006, Archives of general psychiatry.

[96]  L. Launer,et al.  Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study. , 2008, Archives of general psychiatry.

[97]  E. Gudayol-Ferré,et al.  Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder. , 2009, Journal of psychiatric research.

[98]  F. Angelucci,et al.  BDNF in schizophrenia, depression and corresponding animal models , 2005, Molecular Psychiatry.

[99]  Zubenko Gs Biological correlates of clinical heterogeneity in primary dementia , 1992 .

[100]  G. Zubenko Biological correlates of clinical heterogeneity in primary dementia. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[101]  Klaus P. Ebmeier,et al.  White matter hyperintensities in late life depression: a systematic review , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[102]  Maja O’Connor LONGITUDINAL STUDY , 2013 .

[103]  Eric J. Nestler,et al.  The molecular neurobiology of depression , 2008, Nature.

[104]  Michael A Rapp,et al.  Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. , 2006, Archives of general psychiatry.

[105]  L. Bouter,et al.  Depressive Symptoms and Risk of Alzheimer's Disease in More Highly Educated Older People , 2000, Journal of the American Geriatrics Society.

[106]  D. Diamond,et al.  Acute predator stress impairs the consolidation and retrieval of hippocampus-dependent memory in male and female rats. , 2008, Learning & memory.

[107]  Alan J. Thomas,et al.  Depression and vascular disease: what is the relationship? , 2004, Journal of affective disorders.

[108]  B. Ravnkilde,et al.  Hippocampal volume and depression: a meta-analysis of MRI studies. , 2004, The American journal of psychiatry.

[109]  D. Bennett,et al.  Depressive symptoms, cognitive decline, and risk of AD in older persons , 2002, Neurology.

[110]  Anne Corbett,et al.  Depression and dementia. , 2011, Mental health today.

[111]  R. Hébert,et al.  Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. , 2002, American journal of epidemiology.

[112]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[113]  Jason Brandt,et al.  Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. , 2003, Archives of general psychiatry.

[114]  O. Wolkowitz,et al.  Glucocorticoids. Mood, memory, and mechanisms. , 2009, Annals of the New York Academy of Sciences.

[115]  G. Alexopoulos Vascular Disease, Depression, and Dementia , 2003, Journal of the American Geriatrics Society.

[116]  W. M. van der Flier,et al.  Hippocampal atrophy in Alzheimer disease: Age matters , 2006, Neurology.

[117]  H. Kraemer,et al.  Untreated depression and hippocampal volume loss. , 2003, The American journal of psychiatry.

[118]  H. Sackeim,et al.  Sertraline treatment of elderly patients with depression and cognitive impairment , 2003, International journal of geriatric psychiatry.

[119]  D. Steffens,et al.  Geriatric depression and cognitive impairment , 2007, Psychological Medicine.

[120]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.

[121]  M. Mattson,et al.  Adverse Stress, Hippocampal Networks, and Alzheimer’s Disease , 2010, NeuroMolecular Medicine.

[122]  Victoria Arango,et al.  Volumetric Analysis of the Prefrontal Cortex, Amygdala, and Hippocampus in Major Depression , 2004, Neuropsychopharmacology.

[123]  J. Kramer,et al.  Mild cognitive impairment, dementia, and their subtypes in oldest old women. , 2011, Archives of neurology.

[124]  A. Mowla,et al.  Does Fluoxetine Have Any Effect on the Cognition of Patients With Mild Cognitive Impairment?: A Double-Blind, Placebo-Controlled, Clinical Trial , 2007, Journal of clinical psychopharmacology.

[125]  I. Skoog,et al.  Depression as a Risk Factor for the Incidence of First-Ever Stroke in 85-Year-Olds , 2008, Stroke.

[126]  Y. Ihara,et al.  Alzheimer's disease: β‐Amyloid protein and tau , 2002, Journal of neuroscience research.

[127]  M. Webster,et al.  Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium , 2004, Molecular Psychiatry.

[128]  L. Flicker Cardiovascular risk factors, cerebrovascular disease burden, and healthy brain aging. , 2010, Clinics in geriatric medicine.

[129]  R. Levy,et al.  Clinical and neuropathological correlates of depression in Alzheimer's disease , 1992, Psychological Medicine.

[130]  Shawn F. Sorrells,et al.  An inflammatory review of glucocorticoid actions in the CNS , 2007, Brain, Behavior, and Immunity.

[131]  R. Barber,et al.  Pathologies and Pathological Mechanisms for White Matter Hyperintensities in Depression , 2002, Annals of the New York Academy of Sciences.

[132]  C. Ballard,et al.  The prevalence, associations and symptoms of depression amongst dementia sufferers. , 1996, Journal of affective disorders.

[133]  H. Wagner,et al.  Hippocampal volume and incident dementia in geriatric depression. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[134]  Kathryn Ziegler-Graham,et al.  Forecasting the global burden of Alzheimer’s disease , 2007, Alzheimer's & Dementia.

[135]  G. Aliev,et al.  Integrated treatment approach improves cognitive function in demented and clinically depressed patients , 2005, American journal of Alzheimer's disease and other dementias.

[136]  K. Krishnan,et al.  MRI-defined vascular depression. , 1997, The American journal of psychiatry.

[137]  M. Schwald,et al.  Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. , 2005, Brain research. Molecular brain research.

[138]  I. McKeith,et al.  Anxiety, depression and psychosis in vascular dementia: prevalence and associations. , 2000, Journal of affective disorders.

[139]  F J Durgin,et al.  Depression in the elderly. , 1978, Comprehensive therapy.

[140]  J. D. McGaugh,et al.  Glucocorticoids Increase Amyloid-β and Tau Pathology in a Mouse Model of Alzheimer’s Disease , 2006, The Journal of Neuroscience.

[141]  H. Soininen,et al.  Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease , 2010, Annals of neurology.

[142]  K. Yaffe,et al.  Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. , 2012, Archives of general psychiatry.

[143]  Ki Woong Kim,et al.  Depression in Vascular Dementia Is Quantitatively and Qualitatively Different from Depression in Alzheimer’s Disease , 2006, Dementia and Geriatric Cognitive Disorders.

[144]  D. Perl,et al.  Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[145]  L. Schneider,et al.  Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes. , 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[146]  Shijing Huang,et al.  Vascular depression , 2010 .